Table 1 Clinical and biochemical data of the study population

Age (Years)

60.65 ± 11.72

61.52 ± 11.61

63.05 ± 11.79^##

64.61 ± 10.95^&&

Sex (male/female)

109/102

127/119

126/106^##

119/115 ^&&

SBP (mmHg)

124.49 ± 14.90

141.26 ± 24.43***

129.43 ± 22.18^##

140.30 ± 24.86^&&&

DBP (mmHg)

77.03 ± 10.75

81.60 ± 15.34***

79.32 ± 16.67

83.12 ± 14.73^&&&

Hypertension (%)

–

96(38.8%)

59(25.4%)

145(61.9%)

Dyslipidemia (%)

–

96(38.8%)

41(17.6%)

54(23.0%)

Smokers (%)

41(19.4%)

46(18.6%)

74(31.8%)^##

56(23.9%)

Glucose (mg/dL)

5.29 ± 1.27

14.29 ± 6.16***

5.26 ± 1.16

8.86 ± 3.34^&&&

Triglyceride (mg/dL)

1.59 ± 0.93

2.75 ± 3.64***

1.50 ± 0.96

2.28 ± 1.75^&&&

TC (mg/dL)

4.21 ± 1.29

5.67 ± 1.84***

5.02 ± 1.21^###

5.00 ± 1.36^&&&

LDL-C (mg/dL)

2.31 ± 0.88

3.12 ± 1.06***

2.81 ± 0.91^###

2.76 ± 0.99^&&&

HDL-C (mg/dL)

1.33 ± 0.43

1.27 ± 0.37

1.32 ± 0.34

1.17 ± 0.32^&&&

ApoA1 (mg/dL)

1.08 ± 0.36

1.17 ± 0.33**

1.13 ± 0.28

1.09 ± 0.31

ApoB (mg/dL)

0.72 ± 0.27

0.96 ± 0.33***

0.84 ± 0.26^###

0.88 ± 0.31^&&